Cyclic Helix B Peptide in Preservation Solution and Autologous Blood Perfusate Ameliorates Ischemia-Reperfusion Injury in Isolated Porcine Kidneys

Transplantation Direct

Volumn 1, Issue 2, 2015, Pages E6-

  Yang, Cheng ^a   Hosgood, Sarah A ^b   Meeta, Patel ^b   Long, Yaqiu ^c   Zhu, Tongyu ^a   Nicholson, Michael L ^b   Yang, Bin ^b,d  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^d NANTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84946840205     PISSN: None     EISSN: 23738731     Source Type: Journal    
DOI: 10.1097/TXD.0000000000000515     Document Type: Article

References (41)

1. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol. 2006;17(6):1503.
2. Butler AJ, Randle LV, Watson CJ. Normothermic regional perfusion for donation after circulatory death without prior heparinization. Transplantation. 2014;97(12):1272.
3. Hu L, Yang C, Zhao T, et al. Erythropoietin ameliorates renal ischemia and reperfusion injury via inhibiting tubulointerstitial inflammation. J Surg Res. 2012;176(1):260.
4. Yang B, Hosgood SA, Nicholson ML. Naked small interfering RNA of caspase-3 in preservation solution and autologous blood perfusate protects isolated ischemic porcine kidneys. Transplantation. 2011;91 (5):501.
5. Bagul A, Hosgood SA, Kaushik M, Nicholson ML. Effects of erythropoietin on ischaemia/reperfusion injury in a controlled nonheart beating donor kidney model. Transpl Int. 2008;21(5):495.
6. Brines M, Cerami A. Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response. J Intern Med. 2008;264(5):405.
7. Lippi G, Franchini M, Favaloro EJ. Thrombotic complications of erythropoiesis-stimulating agents. Semin Thromb Hemost. 2010;36(5):537.
8. Rosenzweig MQ, Bender CM, Lucke JP, Yasko JM, Brufsky AM. The decision to prematurely terminate a trial of R-HuEPO due to thrombotic events. J Pain Symptom Manage. 2004;27(2):185.
9. Velly L, Pellegrini L, Guillet B, Bruder N, Pisano P. Erythropoietin 2nd cerebral protection after acute injuries: a double-edged sword? Pharmacol Ther. 2010;128(3):445.
10. Patel NS, Kerr-Peterson HL, Brines M, et al. The delayed administration of pHBSP, a novel non-erythropoietic analogue of erythropoietin, attenuates acute kidney injury. Mol Med. 2012;18(3):719.
11. Ehrenreich H, Hasselblatt M, Dembowski C, et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med. 2002;8(8):495.
12. Erbayraktar Z, Erbayraktar S, Yilmaz O, Cerami A, Coleman T, Brines M. Nonerythropoietic tissue protective compounds are highly effective facilitators of wound healing. Mol Med. 2009;15(7–8):235.
13. Brines M, Patel NS, Villa P, et al. Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proc Natl Acad Sci U S A. 2008;105(31):10925.
14. Yang C, Xu Z, Zhao Z, et al. A novel proteolysis-resistant cyclic helix b peptide ameliorates kidney ischemia reperfusion injury. Biochim Biophys Acta. 2014.
15. Hosgood SA, Bagul A, Yang B, Nicholson ML. The relative effects of warm and cold ischemic injury in an experimental model of nonheartbeating donor kidneys. Transplantation. 2008;85(1):88.
16. Harper SJF, Hosgood SA, Waller HL, et al. The effect of warm ischemic time on renal function and injury in the isolated hemoperfused kidney. Transplantation. 2008;86(3):445.
17. Hosgood SA, Yang B, Bagul A, Mohamed IH, Nicholson ML. A comparison of hypothermic machine perfusion versus static cold storage in an experimental model of renal ischemia reperfusion injury. Transplantation. 2010;89(7):830.
18. Casal M, Haskins M. Large animal models and gene therapy. Eur J Hum Genet. 2006;14(3):266.
19. Hosgood SA, Bagul A, Nicholson ML. Minimising cold ischaemic injury in an experimental model of kidney transplantation. Eur J Clin Invest. 2011;41(3):233.
20. Yang C, Jia Y, Zhao T, et al. Naked caspase 3 small interfering RNA is effective in cold preservation but not in autotransplantation of porcine kidneys. J Surg Res. 2013;181(2):342.
21. Yang C, Zhao T, Zhao Z, et al. Serum-stabilized naked caspase-3 siRNA protects autotransplant kidneys in a porcine model. Mol Ther. 2014.
22. Zhao Z, Yang C, Li L, et al. Increased peripheral and local soluble FGL2 in the recovery of renal ischemia reperfusion injury in a porcine kidney autotransplantation model. J Transl Med. 2014;12:53.
23. Yang C, Zhao T, Lin M, et al. Helix B surface peptide administered after insult of ischemia reperfusion improved renal function, structure and apoptosis through beta common receptor/erythropoietin receptor and PI3K/ Akt pathway in a murine model. Exp Biol Med(Maywood). 2013;238(1):111.
24. Gao W, Dong X, Xie N, et al. Dehydroabietic acid isolated from Commiphora opobalsamum causes endothelium-dependent relaxation of pulmonary artery via PI3K/Akt-eNOS signaling pathway. Molecules. 2014;19(6):8503.
25. Wang SG, Xu Y, Chen JD, Yang CH, Chen XH. Astragaloside IV stimulates angiogenesis and increases nitric oxide accumulation via JAK2/STAT3 and ERK1/2 pathway. Molecules. 2013;18(10):12809.
26. Wolfs TGAM, de Vries B, Walter SJ, et al. Apoptotic cell death is initiated during normothermic ischemia in human kidneys. Am J Transplant. 2005;5(1):68.
27. Salahudeen AK, Huang H, Joshi M, Moore NA, Jenkins JK. Involvement of the mitochondrial pathway in cold storage and rewarming-associated apoptosis of human renal proximal tubular cells. Am J Transplant. 2003;3(3):273.
28. Dang Y, Yang Q, Xue Z, Liu Y. RNA interference in fungi: pathways, functions, and applications. Eukaryot Cell. 2011;10(9):1148.
29. Yang B, Hosgood SA, Bagul A, Waller HL, Nicholson ML. Erythropoietin regulates apoptosis, inflammation and tissue remodelling via caspase-3 and IL-1beta in isolated hemoperfused kidneys. Eur J Pharmacol. 2011;660(2–3):420.
30. Chen L, Smith L, Wang Z, Smith JB. Preservation of caspase-3 subunits from degradation contributes to apoptosis evoked by lactacystin: any single lysine or lysine pair of the small subunit is sufficient for ubiquitination. Mol Pharmacol. 2003;64(2):334.
31. Yang CW, Li C, Jung JY, et al. Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. Faseb J. 2003;17(10):1754.
32. Walsh KB, Toledo AH, Rivera-Chavez FA, Lopez-Neblina F, Toledo-Pereyra LH. Inflammatory mediators of liver ischemia-reperfusion injury. Exp Clin Transplant. 2009;7(2):78.
33. Xu B, Dong GH, Liu H, Wang YQ, Wu HW, Jing H. Recombinant human erythropoietin pretreatment attenuates myocardial infarct size: a possible mechanism involves heat shock protein 70 and attenuation of nuclear factor-kappaB. Ann Clin Lab Sci. 2005;35(2):161.
34. Mestril R, Chi SH, Sayen MR, Oreilly K, Dillmann WH. Expression of inducible stress protein-70 in rat-heart myogenic cells confers protection against simulated ischemia-induced injury. J Clin Investig. 1994;93(2):759.
35. Plumier JCL, Ross BM, Currie RW, et al. Transgenic mice expressing the human heat-shock protein-70 have improved postischemic myocardial recovery. J Clin Investig. 1995;95(4):1854.
36. Ribeil JA, Zermati Y, Vandekerckhove J, et al. Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1. Nature. 2007;445(7123):102.
37. Sureshkumar KK, Hussain SM, Ko TY, Thai NL, Marcus RJ. Effect of high-dose erythropoietin on graft function after kidney transplantation: a randomized, double-blind clinical trial. Clin J Am Soc Nephrol. 2012;7 (9):1498.
38. Hafer C, Becker T, Kielstein JT, et al. High-dose erythropoietin has no effect on short- or long-term graft function following deceased donor kidney transplantation. Kidney Int. 2012;81(3):314.
39. Martinez F, Kamar N, Pallet N, et al. High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: results of the Neo-PDGF Study. Am J Transplant. 2010;10(7):1695.
40. Ahmet I, Tae HJ, Juhaszova M, et al. A small nonerythropoietic helix B surface peptide based upon erythropoietin structure is cardioprotective against ischemic myocardial damage. Mol Med. 2011;17(3–4):194.
41. van Rijt WG, van Goor H, Ploeg RJ, Leuvenink HG. Erythropoietin-mediated protection in kidney transplantation: nonerythropoietic EPO derivatives improve function without increasing risk of cardiovascular events. Transpl Int. 2014;27(3):241.